Researchers have found in a new study that cardiovascular disease (CVD) is associated with a higher risk of developing nonmelanoma skin cancer (NMSC), with obesity and inflammation partially mediating this…
Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers have uncovered a key genetic factor that worsens the condition.…
Researchers have found in a new study that adjunctive melatonin therapy significantly improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and periodontitis. These findings suggest melatonin may…
Researchers have found in a small controlled study that a single 25 mg dose of amphetamine-dextroamphetamine (Adderall) in healthy individuals without ADHD led to increased blood pressure, heart rate, and…
USA: New research has revealed that chronic rhinosinusitis (CRS) is associated with an increased risk of developing asthma and future exacerbations. The presence of coexisting allergic rhinitis (AR) identifies a…
A new study published in the journal of BMC Surgery found that the incidence of Frey syndrome was similar across surgical techniques. However, monopolar cautery showed a trend toward a…
Eli Lilly and the "societal obligation" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout newsletter.
Merck intends to buy Terns Pharmaceuticals, the developer of a promising leukemia treatment, for $6.7 billion
New Delhi: The Union Minister of State for Health recently informed the parliament that according to the National Medical Commission (NMC), the number of MBBS seats in the country has…
On the lookout for its next blockbusters, Merck said it would buy Terns Pharmaceuticals, picking up a promising leukemia treatment.